Literature DB >> 8940040

Cyclic AMP induces apolipoprotein E binding activity and promotes cholesterol efflux from a macrophage cell line to apolipoprotein acceptors.

J D Smith1, M Miyata, M Ginsberg, C Grigaux, E Shmookler, A S Plump.   

Abstract

RAW 264 mouse macrophage cells were stably transfected with human apolipoprotein E (apoE) expression vectors. Clonal derivatives were characterized for expression of the human apoE2, apoE3, and apoE4 isoforms. An apoE4-expressing clonal cell line and a non-expressing clonal control cell line were loaded overnight with either [3H]cholesterol or [3H]choline. The cells were washed and incubated for 24 h in serum-free medium with or without the addition of 8-bromo-cyclic AMP (8-Br-cAMP). Only the apoE-secreting cells and only in the presence of 8-Br-cAMP released large amounts of labeled cholesterol or phosphatidylcholine into the medium. Mass analyses of cellular free and esterified cholesterol confirmed the results of the labeling studies; a decrease in cellular cholesterol content was observed in the 8-Br-cAMP-treated apoE-secreting cells, concurrent with an increase in cholesterol found in the medium. FPLC analysis of the medium demonstrated that 8-Br-cAMP treatment of the apoE-secreting cells led to an increased size fraction and amount of a peak of secreted cholesterol which comigrated with apoE. The 8-Br-cAMP-mediated increase in cholesterol efflux was also observed in non-apoE-secreting cells incubated with exogenous apoE or apoAI, and the effect of apoE was saturable. The apoE2, apoE3, and apoE4 isoforms were equally efficient in promoting 8-Br-cAMP-dependent cholesterol efflux. Reductive methylation of apoE abolished its ability to promote 8-Br-cAMP-dependent cholesterol efflux. Brefeldin A and monensin, inhibitors of protein processing through the Golgi, both blocked the 8-Br-cAMP stimulation of cholesterol efflux to exogenous apoE. 8-Br-cAMP induced specific apoE and apoAI binding, but not apoE degradation, by the RAW cells. We present a model wherein cAMP induces a membrane apolipoprotein receptor that does not lead to endocytosis and degradation, but instead promotes the transfer of lipids to apolipoproteins, which can then be released from the cell.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8940040     DOI: 10.1074/jbc.271.48.30647

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  Effluxed lipids: Tangier Island's latest export.

Authors:  M W Freeman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

2.  Characterization of apoA-I-dependent lipid efflux from adipocytes and role of ABCA1.

Authors:  Alisha D Howard; Philip B Verghese; Estela L Arrese; Jose L Soulages
Journal:  Mol Cell Biochem       Date:  2010-06-10       Impact factor: 3.396

3.  Estrogen-induced regulation of the ATP-binding cassette transporter A1 (ABCA1) in mice: a possible mechanism of atheroprotection by estrogen.

Authors:  Rai Ajit K Srivastava
Journal:  Mol Cell Biochem       Date:  2002-11       Impact factor: 3.396

4.  HDL from apoA1 transgenic mice expressing the 4WF isoform is resistant to oxidative loss of function.

Authors:  Stela Z Berisha; Greg Brubaker; Takhar Kasumov; Kimberly T Hung; Patricia M DiBello; Ying Huang; Ling Li; Belinda Willard; Katherine A Pollard; Laura E Nagy; Stanley L Hazen; Jonathan D Smith
Journal:  J Lipid Res       Date:  2015-01-05       Impact factor: 5.922

5.  Acrolein modification impairs key functional features of rat apolipoprotein E: identification of modified sites by mass spectrometry.

Authors:  Tuyen N Tran; Malathi G Kosaraju; Shiori Tamamizu-Kato; Olayemi Akintunde; Ying Zheng; John K Bielicki; Kent Pinkerton; Koji Uchida; Yuan Yu Lee; Vasanthy Narayanaswami
Journal:  Biochemistry       Date:  2014-01-08       Impact factor: 3.162

Review 6.  ATP binding cassette transporter A1--key roles in cellular lipid transport and atherosclerosis.

Authors:  Neelam Srivastava
Journal:  Mol Cell Biochem       Date:  2002-08       Impact factor: 3.396

7.  Apolipoprotein A-I Helsinki promotes intracellular acyl-CoA cholesterol acyltransferase (ACAT) protein accumulation.

Authors:  Juan D Toledo; Horacio A Garda; Laura V Cabaleiro; Angela Cuellar; Magali Pellon-Maison; Maria R Gonzalez-Baro; Marina C Gonzalez
Journal:  Mol Cell Biochem       Date:  2013-03-03       Impact factor: 3.396

8.  The role of hydrophobic and negatively charged surface patches of lipid-free apolipoprotein A-I in lipid binding and ABCA1-mediated cholesterol efflux.

Authors:  Loren E Smith; W Sean Davidson
Journal:  Biochim Biophys Acta       Date:  2009-09-24

9.  Hydrogen-rich water decreases serum LDL-cholesterol levels and improves HDL function in patients with potential metabolic syndrome.

Authors:  Guohua Song; Min Li; Hui Sang; Liying Zhang; Xiuhong Li; Shutong Yao; Yang Yu; Chuanlong Zong; Yazhuo Xue; Shucun Qin
Journal:  J Lipid Res       Date:  2013-04-22       Impact factor: 5.922

10.  Enhanced placental cholesterol efflux by fetal HDL in Smith-Lemli-Opitz syndrome.

Authors:  Katie T Jenkins; Louise S Merkens; Matthew R Tubb; Leslie Myatt; W Sean Davidson; Robert D Steiner; Laura A Woollett
Journal:  Mol Genet Metab       Date:  2008-03-17       Impact factor: 4.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.